Neurocrine Biosciences Inc

Insider Reports History

Location
San Diego, CA
Signature
/s/ Darin Lippoldt, Chief Legal Officer & Corporate Secretary
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Neurocrine Biosciences Inc:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Voyager Therapeutics, Inc. 10%+ Owner Common Stock 8.58M $61.3M $7.15 23 Feb 2023 Direct

Insider Reports Filed by Neurocrine Biosciences Inc

Symbol Company Period Transactions Value $ Form Type Role Filing Time
VYGR Voyager Therapeutics, Inc. 23 Feb 2023 1 $39M 4 10%+ Owner 24 Feb 2023, 05:15